MedTrace Logo

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

NCT05634447 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2023-10-06

No results posted yet for this study

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-391

Conditions

  • Dyslipidemias

Interventions

DRUG

Drug: CKD-391, QD, PO

Drug: CKD-331, D337 QD, PO

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2023-02-27
Completion
2023-06-07

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05634447 on ClinicalTrials.gov